Product
hepalatide
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
A Randomized, Double-blind, Placebo-Controlled, Repeat-Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of L47 in Subjects With Type 2 Diabetes Mellitus on Stable MetforminStatus: Withdrawn, Estimated PCD: 2025-12-01